Bernard D. Naughton

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Paul N. Newton, Katherine C. Bond, Moji Christianah Adeyeye et al. · The Lancet Global Health · 2020 · 167 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +10

Global access to quality-assured medical products: the Oxford Statement and call to action

Paul N. Newton, Katherine C. Bond, Paul N. Newton et al. · The Lancet Global Health · 2019 · 56 citations · Full text

Pharmacy, Pharmaceutical Policy, Global Health +15

Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care

Bernard D. Naughton, Lindsey Roberts, Sue Dopson et al. · BMJ Open · 2017 · 37 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacy Practice +17

Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation

Bernard D. Naughton, Sue Dopson, Tatiana Iakovleva · Journal of Responsible Innovation · 2023 · 27 citations · Full text

Management, Innovation Management, Digital Transformation +12

Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study

Bernard D. Naughton, Lindsey Roberts, Sue Dopson et al. · BMJ Open · 2016 · 26 citations · Full text

Pharmacy, Hospital Pharmacy, Pharmacy Practice +17